COMPILEDopen profilenot managed by this scholar
X
Xuan Dung Pham
Researcher Profile 5/10Link copied
Information
- 🏛️Affiliation: Pham Ngoc Thach University of Medicine
- 🔬Field: Medicine and Pharmacy
- ✍️Profile incomplete — add information
An h-index of 6 places this researcher in Medicine and Pharmacy, within the top 25% of 6,619 profiles in this field in our directory.
Featured publications
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial3,378 citations
The Lancet · 2019 · DOI
The Lancet · 2019 · DOI
Household Financial Burden and Poverty Impacts of Cancer Treatment in Vietnam67 citations
BioMed Research International · 2017 · DOI
BioMed Research International · 2017 · DOI
Protocol for the ROSE sustainment (ROSES) study, a sequential multiple assignment randomized trial to determine the minimum necessary intervention to maintain a postpartum depression prevention program in prenatal clinics serving low-income women52 citations
Implementation Science · 2018 · DOI
Implementation Science · 2018 · DOI
4O First-line (1L) osimertinib (osi) ± platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: FLAURA2 post-progression outcomes24 citations
ESMO Open · 2024 · DOI
ESMO Open · 2024 · DOI
Pathogenic Variant Profile of Hereditary Cancer Syndromes in a Vietnamese Cohort23 citations
Frontiers in Oncology · 2022 · DOI
Frontiers in Oncology · 2022 · DOI
Prevalence and Determinants of Medication Adherence among Patients with HIV/AIDS in Southern Vietnam10 citations
Infectious Disease Reports · 2021 · DOI
Infectious Disease Reports · 2021 · DOI
Response to a Combination of Full-Dose Osimertinib and Ceritinib in a Non-Small Cell Lung Cancer Patient with EML4-ALK Rearrangement and Epidermal Growth Factor Receptor Co-Mutation4 citations
Case Reports in Oncology · 2021 · DOI
Case Reports in Oncology · 2021 · DOI
630MO First-line (1L) osimertinib (osi) ± platinum-pemetrexed chemotherapy (CTx) for EGFR-mutated (EGFRm) advanced non-small cell lung cancer (NSCLC): FLAURA2 Asian cohort4 citations
Annals of Oncology · 2024 · DOI
Annals of Oncology · 2024 · DOI
Optimization Toolpath Generation for Drill Hole on Three Axes CNC Machine Using Genetic Algorithms1 citations
Lecture notes in mechanical engineering · 2024 · DOI
Lecture notes in mechanical engineering · 2024 · DOI
Prediction of Optimal Tool Path for Drilling Based on Ant Colony Algorithm1 citations
Lecture notes in mechanical engineering · 2024 · DOI
Lecture notes in mechanical engineering · 2024 · DOI
About the field of Medicine and Pharmacy
Common research topics in this field:
Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions
Institutions with the most researchers in this field:
Hanoi Medical University · 422
University of Medicine and Pharmacy at Ho Chi Minh City · 418
Vietnam National University Ho Chi Minh City · 393
Can Tho University · 311
Hue University · 240
These figures count profiles currently in this directory, not nationwide statistics.
Same institution — Pham Ngoc Thach University of Medicine
Same field Medicine and Pharmacy
The publication list above is compiled from the open academic database OpenAlex (CC0 licence). Compare with the source record on OpenAlex ↗
Suggest / Claim this profile
Xuan Dung PhamPham Ngoc Thach University of Medicine
Claim
Original profile stored athocthuat.vn— two pages display the same database, verification syncs everywhere.